Navigation Links
University of Pennsylvania joins Actinium Pharmaceuticals' Multicenter Actimab-A Trial
Date:1/17/2013

c. is a public New York, New York based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.

For more information:

Visit our web site www.actiniumpharmaceuticals.com or contact:

Jack Talley , CEO
Actinium Pharmaceuticals Inc.
Tel:  (646) 459-4201
E-mail: jtalley@actiniumpharmaceuticals.com

Investors:
Jeff Ramson
ProActive Capital Group, LLC
Tel:  (646) 863-6341
E-mail: jramson@proactivecrg.com
www.proactivecrg.com  

Media:
Dennis S. Dobson Jr. , 203-258-0159
www.dobsonmediagroup.com

Forward-Looking Statement for Actinium Pharmaceuticals, Inc.
This news release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential, or financial performance.  No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Actinium Pharmaceuticals undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or
'/>"/>

SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. KNODE & the University of Louisville Announce Partnership: New site links UofL experts to world
2. University of Washington Leads All SynCardia Certified Centers with 10 Implants of the Total Artificial Heart in 2012
3. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
4. Ameritox and Wake Forest University Form Research Partnership
5. University Hospitals and Philips Healthcare to Showcase State-of-the-art Imaging Technology at Cleveland Medical Mart
6. Elsevier and University of Surrey Sign Access Agreement to SciVal Strata
7. What Can Healthcare Professionals Learn from Art? A Columbia University Physician Finds Answers at the Met
8. The University of Munich Hospital and Clinics Selects Brainlab Buzz Digital O.R. to Equip All 32 Operating Rooms in New Grobhadern Surgical Building
9. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
10. Oncology Systems Limited UK Renews Research and Collaboration Agreement with University Hospital Birmingham NHS Foundation Trust (UHB) - Radiotherapy Department
11. Parker Creates Endowed Chair at Cleveland State University for Research in Human Motion and Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SAN and NYSE: SNY ) today announced ... in people with hypercholesterolemia met their primary efficacy endpoint ... lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
(Date:7/30/2014)... July 30, 2014   Bluegrass Vascular Technologies ... innovating lifesaving devices and methods for vascular access, ... Series A financing, which was led by ... deal will allow Bluegrass Vascular to obtain CE ... enhance manufacturing capabilities, and proceed with US regulatory ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... July 27, 2011 Pharmaceutics International, Inc. (Pii), a ... it has added hot melt extrusion (HME) to its ... has purchased a 16mm and an 18mm Leistritz twin ... feasibility studies, using just a few grams of active ...
... Pharmaceuticals, Inc., announced today that the company has ... Angel Investors. The company is using the capital ... orphan receptor (ROR) modulators targeting TH17 T-lymphocytes for ... arthritis, multiple sclerosis, psoriasis and COPD. ...
Cached Medicine Technology:Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology 2Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2
(Date:7/30/2014)... 2014 Decene is an alkene ... of ten carbon atoms with one double bond. ... 1-decenes. It can be used as a co-monomer ... produce epoxides, amines, oxo alcohols, synthetic lubricants, synthetic ... buyers will receive 10% customization on this report. ...
(Date:7/30/2014)... Naomi Fried, PhD, and Alexis Gilroy, ... of the American Telemedicine Association (ATA). The ... a mission to promote professional, ethical and equitable ... technology. , “Both Naomi Fried and Alexis Gilroy, ... and are well known experts in their respective ...
(Date:7/30/2014)... (HealthDay News) -- Clues to whether a person is at ... a new study suggests. Chemical changes to a gene ... spur suicidal thoughts and behaviors, the study,s authors explained. Spotting ... to a patient,s risk for suicide, they said. "Suicide ... been stymied in our prevention efforts because we have no ...
(Date:7/30/2014)... The global digital pathology market was valued at ... grow at a CAGR of 11.8%, to reach an estimated ... is growing and is expected to continue to rise in ... image analysis software enable pathologists to be efficient and this ... the North American market was valued at $128.9 million and ...
(Date:7/30/2014)... release is available in French . ... by Claude Gronfier (Inserm Unit 846: Stem Cell and ... study under real conditions on the body clocks of ... researchers have shown that a particular kind of artificial ... are correctly synchronised despite the absence of sunlight. The ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Dimly lit working environments: Correcting your body clock is possible! 2Health News:Dimly lit working environments: Correcting your body clock is possible! 3Health News:Dimly lit working environments: Correcting your body clock is possible! 4
... Minister Frank Nweke has said in a statement that a ... states//, and one among them is Nigeria’s southern most state. ... the central state of Benue and Port Harcourt in Rivers ... virus. According to Frank, "The culling of infected birds and ...
... treatment of erectile dysfunction or impotence can now be ... disease//. Pfizer, a leading pharmaceutical company, is marketing the ... ,The drug approved for use in last ... the same active ingredients as the pill, Viagra. The ...
... Unilever has announced a partnership with the World Dental ... Middle East and Turkey.// Both organizations will assist National ... spread awareness about the importance of oral health. ... Learn. Laugh. The programs include school education programmes and ...
... Researchers at the University of Illinois at Urbana-Champaign ... nanoparticles to produce new drug and agricultural materials ... materials science and engineering, chemistry and physics said ... hollow, deformable and biofunctional capsules could be used ...
... governor of South Dakota signed a law banning abortions, which ... and also which may trigger national debate. // ... Supreme Court decision, known as Roe vs. Wade, that made ... abortion. ,Governor Mike Rounds, a member of President ...
... back slowly after its steep fall from grace, following the ... bies and on the house access to chicken delicacies have ... onto people’s plates. ,The farm-gate prices had recorded ... 1.20 while the chicken prices had hit rock bottom at ...
Cached Medicine News:Health News:Medical Boon in the Form of a Biofriendly Capsule 2
... Guide 2005 includes over 1,000 commonly used ... their selection and administration. Organized alphabetically by ... key data featuring common uses and side ... patient education information. A list of the ...
... Drugs is a dynamic new mobile ... easy to check on the compatibility ... selected drugs, clear compatibility and stability ... quickly take clinical action based on ...
Providing patients and their advocates with a variety of information services and educational materials on clinical research....
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Medicine Products: